Abstract
Micro RNAs (miRNAs) are short non-coding RNAs of 20-24nt in length mediating RNA silencing, a eukaryotic, sequence-specific repressive gene regulation mechanism. In plants, miRNAs have a pivotal role during fundamental processes such as development, maintenance of genome integrity and abiotic stress responses. They originate from MIRNA genes that are transcribed by RNA polymerase II; MIRNA transcripts form imperfect fold-back structures that are further processed to miRNA duplexes. In Arabidopsis, over 180 MIRNA loci have been identified. Recent evidence shows that miRNAs are substantially implicated in regulating plant immunity. Pathogen attack triggers massive changes in the miRNA transcriptome; many of the altered miRNAs participate in controlling plant hormone pathways. Moreover, microorganisms are known to manipulate silencing pathways to counteract miRNA-mediated defenses. Thus far, miRNAs are believed to likely function as cardinal players in the concert of broad-spectrum disease resistance. Here, we summarize the highlights and latest findings of miRNAs as molecular regulators during plant-microbe interactions.
Keywords: Biotic stress, innate immunity, microRNA, plant defense, plant hormones, small RNAs.
MicroRNA
Title:Small Yet Mighty – MicroRNAs in Plant-Microbe Interactions
Volume: 2 Issue: 1
Author(s): Dirk Balmer and Brigitte Mauch-Mani
Affiliation:
Keywords: Biotic stress, innate immunity, microRNA, plant defense, plant hormones, small RNAs.
Abstract: Micro RNAs (miRNAs) are short non-coding RNAs of 20-24nt in length mediating RNA silencing, a eukaryotic, sequence-specific repressive gene regulation mechanism. In plants, miRNAs have a pivotal role during fundamental processes such as development, maintenance of genome integrity and abiotic stress responses. They originate from MIRNA genes that are transcribed by RNA polymerase II; MIRNA transcripts form imperfect fold-back structures that are further processed to miRNA duplexes. In Arabidopsis, over 180 MIRNA loci have been identified. Recent evidence shows that miRNAs are substantially implicated in regulating plant immunity. Pathogen attack triggers massive changes in the miRNA transcriptome; many of the altered miRNAs participate in controlling plant hormone pathways. Moreover, microorganisms are known to manipulate silencing pathways to counteract miRNA-mediated defenses. Thus far, miRNAs are believed to likely function as cardinal players in the concert of broad-spectrum disease resistance. Here, we summarize the highlights and latest findings of miRNAs as molecular regulators during plant-microbe interactions.
Export Options
About this article
Cite this article as:
Balmer Dirk and Mauch-Mani Brigitte, Small Yet Mighty – MicroRNAs in Plant-Microbe Interactions, MicroRNA 2013; 2 (1) . https://dx.doi.org/10.2174/2211536611302010008
DOI https://dx.doi.org/10.2174/2211536611302010008 |
Print ISSN 2211-5366 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5374 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Effects of Interleukin-10 on the Expression of Fas and FasL in Rat Hepatic Stellate Cells
Medicinal Chemistry Early Growth Response-1 (EGR-1) – A Key player in Myocardial Cell Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry Mechanisms of Anorexia Cancer Cachexia Syndrome and Potential Benefits of Traditional Medicine and Natural Herbs
Current Pharmaceutical Biotechnology Antineoplastic Potential of Medicinal Plants
Recent Patents on Biotechnology Computational Models for Predicting Interactions with Cytochrome p450 Enzyme
Current Topics in Medicinal Chemistry Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease?
Current Pharmaceutical Design Anti-HIV-1 and Anti-HBV Immune Responses in Mice After Parenteral and Nasal Co-Administration of a Multiantigenic Formulation
Current HIV Research Pathophysiology and Management of Atopic Dermatitis: A Laconic Review
Current Drug Therapy The Need for Physiologically Relevant Peroxisome Proliferator-Activated Receptor-gamma (PPAR-γ) Ligands
Endocrine, Metabolic & Immune Disorders - Drug Targets Gene Silencing Mediated by Small Interfering RNAs in Mammalian Cells
Current Medicinal Chemistry Hyperferritinaemia: An Iron Sword of Autoimmunity
Current Pharmaceutical Design Anti-Interleukin-6 Receptor Antibody Treatment in Inflammatory Autoimmune Diseases
Reviews on Recent Clinical Trials Ganglioside GM3 and Its Role in Cancer
Current Medicinal Chemistry Critical Role for IL-15 in Innate Immunity
Current Molecular Medicine Nitric Oxide and Dietary Factors: Part II Cholesterol, Fat, Amino Acids,Proteins and Carbohydrate
Vascular Disease Prevention (Discontinued) Progress in Syntheses of 3-n-Butylphthalide and Its Analogues
Current Organic Chemistry Angiotensin II and Abdominal Aortic Aneurysms: An update
Current Pharmaceutical Design Mechanisms of Cellular Resistance to Camptothecins
Current Medicinal Chemistry Prospects for Gene Therapy of Osteopetrosis
Current Gene Therapy Protein Kinases and Associated Pathways in Pluripotent State and Lineage Differentiation
Current Stem Cell Research & Therapy